Sign in
Enrolling by invitationNo phase

Early program for parents of babies with rare genetic developmental disorders

Tests a parent coaching program for infants under one with rare neurogenetic disorders.

Key facts

Who runs it
RTI International
Where
Research Triangle Park, United StatesSee the site
Trial code
Registry title
Parent and Infant Inter(X)Action Intervention (PIXI)
Status
Enrolling by invitation
People taking part
120 people, planned
Started
30 Nov 2018
Expected to end
31 Dec 2026
Type of study
Interventional
Treatments tested
  • Parent-Infant Inter(X)action Intervention (PIXI)
Record updated
13 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for infants 15 months old or younger with a confirmed neurogenetic disorder, together with their parents or caregivers. English must be the main language at home.

Age
Infants 15 months of age or younger.
Sex
All sexes can join.
Disease stage
A confirmed diagnosis of a neurogenetic disorder, such as fragile X, Angelman, Prader-Willi, Dup15q, Phelan-McDermid, Smith Magenis, Williams or Turner syndrome, or Duchenne muscular dystrophy.
Biomarker or test result
The diagnosis must not have been sought only because of parental concerns about the infant, for example it came from prenatal or newborn screening, or from testing after a family member was diagnosed.

Main reasons for not taking part

  • Infants who are blind
  • Infants with a severe hearing impairment
  • Homes where English is not the main language

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Infants 15 months of age or younger who have received a diagnosis which was not sought solely due to parental concerns about the infant (e.g. diagnosis due to prenatal or newborn screening, cascade testing following diagnosis of a family member)
  • English must be the primary language spoken in the home because all assessment measures and intervention protocol are in English

Who cannot take part

  • Infants may not be blind or have a severe hearing impairment as the intervention and assessments are not appropriate for these children

Where in United States

  • RTI InternationalResearch Triangle Park, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The objective is to develop and test, through an iterative process, an intervention to address and support the development of infants with a confirmed diagnosis of a neurogenetic disorder with associated developmental delays or intellectual and developmental disabilities. The proposed project will capitalize and expand upon existing empirically based interventions designed to improve outcomes for infants with suspected developmental delays.

Read full original descriptionShow less

Participants will be infants with a confirmed diagnosis of a neurogenetic disorder (e.g., fragile X, Angelman, Prader-Willi, Dup15q, Phelan-McDermid, Rhett, Smith Magenis, Williams, Turner, Kleinfelter, Down syndromes, Duchenne muscular dystrophy) within the first year of life and their parents/caregivers.

The intervention, called the Parent and Infant Inter(X)action Intervention (PIXI) is a comprehensive program inclusive of parent education about early infant development and the neurogenetic disorder for which they were diagnosed, direct parent coaching around parent-child interaction, and family/parent well-being support. The protocol includes repeated comprehensive assessments of family and child functioning, along with an examination of feasibility and acceptability of the program.

The group in the trial

  • Infants with a rare neurogenetic condition and their parent/primary caregiver(s)Treatment being tested

    PIXI

    Treatment: Parent-Infant Inter(X)action Intervention (PIXI)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Piloting an Early Intervention Program for Infants With Rare Neurogenetic Disorders
Plain-language title
Early program for parents of babies with rare genetic developmental disordersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
13 July 2026